$WBX Cashflow Statement | Understand Stock

$WBX

$2.67 +$0.02 (0.75%) Close

$WBX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of EUR, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from Operating Activities
Loss for the Year
Adjustments for:
Amortization and depreciation
Impairment of assets
Expected credit loss for trade and other receivables
Impairments of inventories
Impairments of financial assets
Change in provisions
Government grants
Financial income
Financial expenses
Change in fair value of derivative warrant liabilities
Exchange differences
Income tax credit
Fair value change of financial instruments
Others impairments and losses
Share listing expense
Share based payments expense
Results from disposals of property, plant and equipment
Share of loss of equity accounted associates
Negative Goodwill
Proceeds from government grants
Others paid
Changes in
- inventories
- trade and other financial receivables
- other assets
- trade and other financial payables
- other non-current assets and liabilities
- contract liabilities

Net cash from / (used) in operating activities

Cash flows from Investing Activities
Loans granted to Joint Venture
Investment in equity-accounted investees
Loans granted to equity-accounted investees
Acquisition of intangible assets
Acquisition of property, plant and equipment
Acquisition of financial assets at amortized costs
Acquisition of financial assets at fair value through profit or loss
Other financial assets, net
Proceeds from sale of intangible assets
Proceeds from sale of property, plant and equipment
Proceeds from sale of financial assets at amortized costs
Proceeds from sale of financial assets at fair value through profit or loss
Proceeds from sale of financial assets at fair value through other comprehensive income
Acquisition of subsidiaries, net of cash acquired
Net cash from / (used) in investing activities

Cash flows from Financing Activities
Proceeds from issuing equity instruments
ATM
PIPE Financing
Private Placement
Kensington Shareholders
Warrants Conversion And Other
Total proceeds from issuing equity instruments

Issuance Costs
Purchase of share-based payments plan
Proceeds from borrowings
Proceeds from loans
Proceeds from convertible bonds
Repayments of loans
Repayments of related parties loans
Interest paid of convertible bonds
Payment of principal portion of lease liabilities
Payment of interest on lease liabilities
Payment of put option liabilities
Interest and bank fees paid
Other payments
Net cash from financing activities

Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Exchange gains/(losses)
Cash and cash equivalents at 31 December

Comments